MedPath

Metabolic Effects of Morning 16/8 Fasting

Not Applicable
Completed
Conditions
Overweight and Obesity
Interventions
Other: Mediterranean
Other: Low carbohydrate
Other: fasting
Registration Number
NCT04293003
Lead Sponsor
National and Kapodistrian University of Athens
Brief Summary

A study to address the effects of early-day fasting on fat tissue mobilization in comparison to a typical isocaloric Mediterranean and a low-carbohydrate breakfast.

Detailed Description

The study design meets a cross-over pattern with 3 different morning visits of 6 hour duration each. After an informed consent is received from the participant, a crude medical history, physical examination and collection of somatometric data through bio-impendance analysis will take place. An intravenous catheter will be placed in the participants forearm.

At zero time point, depending on study visit, participants will either (A) remain fasted (B) start consuming ta pre-prepared zero-carbohydrate 500 kcal test meal (C) start consuming ta pre-prepared 500 kcal test meal with a composition conforming to a standard Mediterannean breakfast. Participants will be given 10 minutes to consume the meal.

Blood samples will be drawn and visual analogue scales (VAS) for hunger and satiety will be filled in at the following time points (min): -15, 0, 15, 30, 60, 90, 120, 180, 240, 300, 360.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
10
Inclusion Criteria
  • BMI 18-25 kg/m2
  • Willfulness to participate
Exclusion Criteria
  • Overweight or obesity (BMI>25 kg/m2)
  • Type 1 or 2 diabetes mellitus
  • Uncontrolled thyroid disorders

Study & Design

Study Type
INTERVENTIONAL
Study Design
CROSSOVER
Arm && Interventions
GroupInterventionDescription
MediterraneanMediterraneanConsumption of a Mediterranean breakfast
Low carbohydrateLow carbohydrateConsumption of a zero-carbohydrate breakfast
Fastingfasting6-hour morning fasting
Primary Outcome Measures
NameTimeMethod
Mobilisation of adipose tissue6 hours

Area Under the Curve (AUC) of free fatty acid (FFA) and beta-Hydroxybutyrate (bOB) concentration

Secondary Outcome Measures
NameTimeMethod
Mobilisation of gut peptides6 hours

AUC of Ghrelin, Peptide YY and glucagon-like peptide -1 (GLP-1) concentration

Degree of appetite suppression6 hours

Visual Analogue Scale score (0-10, 0 equals minimal and 10 equals highest) for appetite

Degree of satiety induction6 hours

Visual Analogue Scale score (0-10, 0 equals minimal and 10 equals highest) for satiety

Trial Locations

Locations (1)

Diabetes Clinical Research Laboratory, 1st Department of Propaedeutic Internal Medicine

🇬🇷

Athens, Greece

© Copyright 2025. All Rights Reserved by MedPath